Elevated expression of genes connected with metastasis, in cells expressing the Y537S and D538G mutations and increased metastatic potential in tumour xenografts [25–30], also implicates ESR1 mutations in driving transcriptomic reprogramming that promotes metastasis. This evidence concerns the gene ESR1 and neoplasm.